Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1385-1392
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Table 3 Adverse reactions, n (%)
| Group | Nausea and vomiting | Loss of appetite | Phlebitis | Gastrointestinal reaction | Rash | Total incidence rate |
| Dialysis group (n = 45) | 2 (4.44) | 2 (4.44) | 1 (2.22) | 2 (4.44) | 1 (2.22) | 8 (17.78) |
| Joint group (n = 49) | 1 (2.04) | 1 (2.04) | 2 (4.08) | 1 (2.04) | 1 (2.04) | 6 (12.24) |
| χ2 value | 0.566 | |||||
| P value | 0.451 |
- Citation: Ma XY, Sheng YP, Yang XM, Zhang HR, Sun FY. Effects of paricalcitol combined with hemodiafiltration on bone-metabolism-related indexes in patients with diabetic nephropathy and chronic renal failure. World J Diabetes 2023; 14(9): 1385-1392
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1385.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1385